Position in FATE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,054,876
+$743,394 QoQ
Shares Held
3,379,064
0.0% QoQ
Ownership
2.90%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JOHNSON & JOHNSON holds $604,852,239 across 12 Biotechnology names. FATE ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
2,449,183 | $258,143,888 | |
| 2 | NBTX |
Nanobiotix S.A.
|
5,623,816 | $173,607,199 | |
| 3 | MGTX |
MeiraGTx Holdings plc
|
6,641,064 | $57,511,614 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
1,784,517 | $55,837,536 | |
| 5 | CTNM |
Contineum Therapeutics, Inc.
|
1,979,173 | $25,847,999 | |
| 6 | LEGN |
Legend Biotech Corp
|
814,586 | $14,735,860 | |
| 7 | XNCR |
Xencor Inc
|
748,062 | $9,021,627 | |
| 8 | FATE |
Fate Therapeutics Inc
This page
|
3,379,064 | $4,054,876 |
All Filings in FATE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,054,876 | 3,379,064 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,311,482 | 3,379,064 | Shares | Defined | 2026-03-18 | |
| 2025-09-30 | $4,257,620 | 3,379,064 | Shares | Defined | 2026-03-18 | |
| 2025-06-30 | $3,784,551 | 3,379,064 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $2,669,460 | 3,379,064 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $5,575,455 | 3,379,064 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $11,826,724 | 3,379,064 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $11,083,329 | 3,379,064 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $24,802,329 | 3,379,064 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $12,637,699 | 3,379,064 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,163,615 | 3,379,064 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $16,084,344 | 3,379,064 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $19,260,664 | 3,379,064 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $34,094,755 | 3,379,064 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $75,724,824 | 3,379,064 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $83,733,205 | 3,379,064 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $131,006,311 | 3,379,064 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $197,709,034 | 3,379,064 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $200,277,123 | 3,379,064 | Shares | Defined | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||